Poseida Therapeutics, Inc. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Poseida Therapeutics, Inc. reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $3.09 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-07.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2024-03-07
- Poseida Therapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $3.09M, a 28.63% increase from fiscal 2022.
- Poseida Therapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $2.40M, a 41.46% decline from fiscal 2021.
- Poseida Therapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2021 was $4.11M, a 27.84% increase from fiscal 2020.
- Poseida Therapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2020 was $3.21M, a 87.23% increase from fiscal 2019.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2023-12-31 | $3.09M 10-K · filed 2024-03-07 |
| 2022-12-31 | $2.40M 10-K · filed 2024-03-07 |
| 2021-12-31 | $4.11M 10-K · filed 2023-03-09 |
| 2020-12-31 | $3.21M 10-K · filed 2022-03-10 |
| 2019-12-31 | $1.72M 10-K · filed 2021-03-11 |